Oncodesign and Servier reach a key first milestone in their strategic partnership on LRRK2 inhibitors for Parkinson’s Disease
17/02/20
Press releases 2020
Oncodesign announces a 33% revenue increase in 2019 and the achievement of financial breakeven one year ahead of schedule
20/01/20